Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Fundraising
Biotech
Fierce Biotech Fundraising Tracker: Ribon, Grey Wolf and more
Alongside the new year, we've launched a new Fierce Biotech Fundraising Tracker.
Gabrielle Masson
,
Max Bayer
,
Annalee Armstrong
Feb 6, 2023 11:36am
The rise of venture debt in biotech and when to use it
Jan 24, 2023 10:05am
Fierce Biotech Fundraising Tracker: Enveda, Enlaza and more
Dec 21, 2022 10:00am
FDA extends review of Gamida Cell's approval by 3 months
Nov 22, 2022 10:55am
FogPharma hauls in $178M series D
Nov 21, 2022 4:33pm
Jnana Therapeutics brings in $107M funds, $2B Roche collab
Nov 15, 2022 6:00am
